Carl N Kraus's Net Worth
$400 Thousand
Who is Carl N Kraus?
Carl N Kraus does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Aquestive Therapeutics, Inc., and Aceragen, Inc..
SEC CIK
Carl N Kraus's CIK is 0001946475
Past Insider Trading and Trends
2022 was Carl N Kraus's most active year for acquiring shares with 3 total transactions. Carl N Kraus's most active month to acquire stocks was the month of August. 2022 saw Carl N Kraus paying a total of $0.00 for 665,050 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aquestive Therapeutics, Inc. (AQST) Snapshot price: $2.6643
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +75.00% | 112.5K |
—
|
—
| 262.5K |
Mar 7
| |||
Form 4
|
∞
| 150K |
—
|
—
| 150K |
Aug 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aceragen, Inc. No price found
CHIEF MEDICAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||